The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and ...

Jim Cramer in a latest program on CNBC discussed the reasons behind the recent market declines after the ISM Services Index ...

With a trading volume of 5,249,687, the price of ABT is down by -0.19%, reaching $122.98. Current RSI values indicate that ...

We recently published a list of 10 Stocks Expected To Post Impressive Earnings This Week. In this article, we are going to ...

Arcblock (ABT) shot up by more than 45% in the past 24 hours and claimed a daily high of $1.92, facing resistance at $2.

Abbott Laboratories (NYSE: ABT) Q4 2024 Earnings Call Jan 22, 2025, 9:30 a.m. ET ...

Oppenheimer has recently initiated Abbott Laboratories (ABT) stock to Outperform rating, as announced on October 8, 2024, according to Finviz. Earlier, on September 19, 2024, Piper Sandler had ...

Abbott Laboratories (ABT) stock traded lower in the premarket on Wednesday after its Q4 2024 results fell short of Street ...

2025 Adjusted Tax Rate Forecast: 16% to 17%. Abbott Laboratories (NYSE:ABT) achieved a 9.5% sales growth excluding COVID testing, demonstrating strong performance across its business segments.

Oppenheimer has recently initiated Abbott Laboratories (ABT) stock to Outperform rating, as announced on October 8, 2024, according to Finviz. Earlier, on September 19, 2024, Piper Sandler had ...